TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35410169

Group type: EXPERIMENTAL
Intervention: Lidocaine local anesthesia
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 80
Study: 34534176

Group type: EXPERIMENTAL
Intervention: Therapeutic stimulation (N = 102)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Low-level sham stimulation (N = 102)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Combined cohort after sham group switched to therapeutic stimulation
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Therapeutic stimulation
Number of subjects: 204
Study: 32827227

Group type: EXPERIMENTAL
Intervention: COAL
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: COAL/RT
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: COAL/WT
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: CP
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: RT
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: WT
Number of subjects: 10

Group type: COMPARATOR
Intervention: CONT
Number of subjects: 10
Study: 35572824

Group type: EXPERIMENTAL
Intervention: Yiqi Huayu Pinggan Zishen recipe combined with valsartan
Number of subjects: 100

Group type: COMPARATOR
Intervention: valsartan
Number of subjects: 100
Study: 32525925

Group type: EXPERIMENTAL
Intervention: Dual antiplatelet therapy for 3 months
Number of subjects: 508

Group type: COMPARATOR
Intervention: Single antiplatelet therapy
Number of subjects: 508
Study: 34933066

Group type: EXPERIMENTAL
Intervention: Twice-weekly hemodialysis with adjuvant pharmacologic therapy for 6 weeks followed by thrice-weekly hemodialysis (incremental HD group)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Thrice-weekly hemodialysis (conventional HD group)
Number of subjects: 51
Study: 35593007

Group type: EXPERIMENTAL
Intervention: Bladder training (BT) + Magnetic stimulation (MStim)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Bladder training (BT) alone
Number of subjects: 76
Study: 33390029

Group type: EXPERIMENTAL
Intervention: X-Bolt Hip System (XHS)
Number of subjects: 1128

Group type: COMPARATOR
Intervention: Sliding hip screw (SHS)
Number of subjects: 1128
Study: 36152982

Group type: EXPERIMENTAL
Intervention: Endovascular aneurysm repair (EVAR)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Conservative management
Number of subjects: 350
Study: 34669886

Group type: EXPERIMENTAL
Intervention: Whey protein supplementation (40 g daily for 15 days)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Casein supplementation (40 g daily for 15 days)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Both interventions (WP and casein)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Patients meeting protein requirements with positive energy balance
Number of subjects: 56
Study: 33243041

Group type: EXPERIMENTAL
Intervention: Caring intervention (physical activity, diet and counseling)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study: 33155296

Group type: EXPERIMENTAL
Intervention: Periodontal treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: OLS models estimating SACE for periodontal treatment
Number of subjects: 0
Study: 36331050

Group type: EXPERIMENTAL
Intervention: Care Ecosystem (CE)
Number of subjects: 490

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 490
Study: 33456346

Group type: EXPERIMENTAL
Intervention: Left stellate ganglion ablation (SGA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Acute stroke (AS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham-operated group
Number of subjects: 20
Study: 32730122

Group type: COMPARATOR
Intervention: 0.05% NaF rinse
Number of subjects: 17

Group type: COMPARATOR
Intervention: 0.2% NaF rinse
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: 0.32% NaF rinse
Number of subjects: 17
Study: 32340530

Group type: EXPERIMENTAL
Intervention: Behavioral mobile health (eHealth) plus health coach
Number of subjects: 150

Group type: COMPARATOR
Intervention: eHealth only
Number of subjects: 150
Study: 35893415

Group type: EXPERIMENTAL
Intervention: Whole-body cryostimulation (WBC)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Multidisciplinary rehabilitation program without WBC
Number of subjects: 43
Study: 32957348

Group type: EXPERIMENTAL
Intervention: LRCC5310 (Group I)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (Group II)
Number of subjects: 50
Study: 34396714

Group type: EXPERIMENTAL
Intervention: iChoose (high intensity, parent-child dyads)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Family Connections (low intensity, parents only)
Number of subjects: 139
Study: 32956960

Group type: EXPERIMENTAL
Intervention: Family Talk Intervention (6-8 sessions)
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Let's Talk about the Children (2-3 sessions)
Number of subjects: 62
Study: 32541504

Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34495425

Group type: EXPERIMENTAL
Intervention: OMDI 0.002% once daily (Group 1 and Group 2)
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: OMDI 0.002% once daily + timolol 0.5% twice daily (Group 3)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (timolol 0.5% twice daily)
Number of subjects: 125
Study: 36464536

Group type: EXPERIMENTAL
Intervention: Popular opinion leader (POL)-led organizational intervention with 4 interactive workshops
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Popular opinion leader (POL)-led organizational intervention
Number of subjects: 263

Group type: COMPARATOR
Intervention: Delayed intervention (control)
Number of subjects: 263
Study: 33591367

Group type: EXPERIMENTAL
Intervention: SBT high-risk group
Number of subjects: 5233

Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 5233

Group type: EXPERIMENTAL
Intervention: Smoking
Number of subjects: 5233

Group type: EXPERIMENTAL
Intervention: Severe baseline disability
Number of subjects: 5233

Group type: EXPERIMENTAL
Intervention: Very severe baseline disability
Number of subjects: 5233

Group type: EXPERIMENTAL
Intervention: Diagnosed depression/anxiety
Number of subjects: 5233

Group type: COMPARATOR
Intervention: 1 nonconcordant process of care
Number of subjects: 5233

Group type: COMPARATOR
Intervention: 2 nonconcordant processes of care
Number of subjects: 5233

Group type: COMPARATOR
Intervention: 3 nonconcordant processes of care
Number of subjects: 5233
Study: 32727483

Group type: EXPERIMENTAL
Intervention: Industrial PM2.5 exposure
Number of subjects: 7600

Group type: EXPERIMENTAL
Intervention: Industrial SO2 exposure
Number of subjects: 7600

Group type: EXPERIMENTAL
Intervention: Combined industrial exposures (PM2.5, SO2, NO2)
Number of subjects: 7600

Group type: EXPERIMENTAL
Intervention: Industrial NO2 exposure
Number of subjects: 7600

Group type: COMPARATOR
Intervention: Regional overall PM2.5 exposure
Number of subjects: 7600
Study: 35239416

Group type: EXPERIMENTAL
Intervention: Avelumab plus axitinib
Number of subjects: 437

Group type: COMPARATOR
Intervention: Sunitinib
Number of subjects: 437
Study: 32065601

Group type: COMPARATOR
Intervention: No prehydration
Number of subjects: 523

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate prehydration (250 mL of 1.4% sodium bicarbonate administered in a 1-hour infusion)
Number of subjects: 523
Study: 35816479

Group type: EXPERIMENTAL
Intervention: Unified Protocol (UP) - Internet-based intervention for 10 weeks
Number of subjects: 129

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 129
Study: 33616456

Group type: EXPERIMENTAL
Intervention: Heavy Slow Resistance (HSR) 90% of 1 RM
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Moderate Slow Resistance (MSR) 55% of 1 RM
Number of subjects: 44
Study: 32453454

Group type: EXPERIMENTAL
Intervention: Pyrimethamine + sulfonamide combinations (P-S)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Spiramycin (Spy)
Number of subjects: 0
Study: 36300123

Group type: EXPERIMENTAL
Intervention: Intraoperative cell salvage (ICS)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Control (allogeneic RBC transfusion)
Number of subjects: 130
Study: 35484069

Group type: EXPERIMENTAL
Intervention: Mindfulness‐Based Therapy for Insomnia (MBTI)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Sleep hygiene education and exercise program (SHEEP)
Number of subjects: 94
Study: 33144141

Group type: EXPERIMENTAL
Intervention: Tailored recommendations
Number of subjects: 955

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 955

Group type: EXPERIMENTAL
Intervention: Tailored recommendations (men)
Number of subjects: 955

Group type: COMPARATOR
Intervention: Control group (men)
Number of subjects: 955
Study: 35841512

Group type: EXPERIMENTAL
Intervention: Smartphone application promoting preschooler's oral health
Number of subjects: 51

Group type: COMPARATOR
Intervention: Common oral health education (educational pamphlet and verbal explanations)
Number of subjects: 51
Study: 33421647

Group type: EXPERIMENTAL
Intervention: Propranolol (2 mg intravenous)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 240
Study: 32379660

Group type: EXPERIMENTAL
Intervention: Sleep education and yoga intervention
Number of subjects: 17
Study: 35921102

Group type: EXPERIMENTAL
Intervention: Active tDCS group (30-minute daily sessions for 4 weeks, 2 mA anodal-right and cathodal-left prefrontal stimulation)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sham tDCS group (sham stimulation)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Active tDCS group
Number of subjects: 64
Study: 32006422

Group type: EXPERIMENTAL
Intervention: Low sodium diet (2.6 g/day)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Medium sodium diet (6.0 g/day)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: High sodium diet (18.0 g/day)
Number of subjects: 21
Study: 33524659

Group type: EXPERIMENTAL
Intervention: Adductor canal block (ACB)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (saline injection)
Number of subjects: 35
Study: 34269813

Group type: EXPERIMENTAL
Intervention: Azithromycin (1.2 g single oral dose)
Number of subjects: 263

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 263
Study: 33382736

Group type: EXPERIMENTAL
Intervention: Continuous Protocol (CP) at PM
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Alternated Protocol (AP) at PM
Number of subjects: 11

Group type: COMPARATOR
Intervention: Continuous Protocol (CP) at AM
Number of subjects: 11

Group type: COMPARATOR
Intervention: Alternated Protocol (AP) at AM
Number of subjects: 11
Study: 34617558

Group type: EXPERIMENTAL
Intervention: MOS-supplemented infant formula (7.2 g MOS/L)
Number of subjects: 326
Study: 32888340

Group type: EXPERIMENTAL
Intervention: Droperidol (5 mg)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Ziprasidone (10 mg)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Ziprasidone (20 mg)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Lorazepam (2 mg)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 115
Study: 34534196

Group type: EXPERIMENTAL
Intervention: Easy-to-read patient education card given at the preoperative visit
Number of subjects: 128

Group type: COMPARATOR
Intervention: Standard surgical counseling
Number of subjects: 128
Study: 32627952

Group type: EXPERIMENTAL
Intervention: Exercise training for 12 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Control group (n = 15)
Number of subjects: 35
Study: 35573181

Group type: EXPERIMENTAL
Intervention: Bean bag chair
Number of subjects: 14

Group type: COMPARATOR
Intervention: Urethane chair
Number of subjects: 14
Study: 33650469

Group type: EXPERIMENTAL
Intervention: Golimumab concentration < 1.0 mg/L
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Golimumab concentration 1.0–3.9 mg/L
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Golimumab concentration ≥ 4.0 mg/L
Number of subjects: 91

Group type: COMPARATOR
Intervention: Serum golimumab concentration < 1.0 mg/L
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: ADAbs detected
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Golimumab concentrations ≥ 1.0 mg/L
Number of subjects: 91
Study: 32832625

Group type: EXPERIMENTAL
Intervention: Customized belonging intervention
Number of subjects: 1063

Group type: COMPARATOR
Intervention: Control groups
Number of subjects: 1063
Study: 32558624

Group type: EXPERIMENTAL
Intervention: Intragastric infusion of fructose (25g)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Water (placebo)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fructose in neutral emotion
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Fructose in sad emotion
Number of subjects: 15
Study: 32901464

Group type: EXPERIMENTAL
Intervention: Transarterial chemoembolization (TACE)
Number of subjects: 750

Group type: EXPERIMENTAL
Intervention: Predictive models based on pre-TACE imaging findings
Number of subjects: 750
Study: 36348331

Group type: EXPERIMENTAL
Intervention: Chondromalacia patella (CMP)
Number of subjects: 22710

Group type: EXPERIMENTAL
Intervention: Chondromalacia patella (CMP) in patients over 65 years old
Number of subjects: 22710

Group type: EXPERIMENTAL
Intervention: Chondromalacia patella (CMP) in women
Number of subjects: 22710

Group type: COMPARATOR
Intervention: Control group (patients without CMP)
Number of subjects: 22710
Study: 33200227

Group type: EXPERIMENTAL
Intervention: Personalized peptide vaccination (PPV)
Number of subjects: 310

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: PPV
Number of subjects: 310

Group type: COMPARATOR
Intervention: PPV and Placebo
Number of subjects: 310
Study: 32182587

Group type: EXPERIMENTAL
Intervention: Short warm-up (8 × 100 m with gradual increase from 60% to 95% of maximal speed with 1-min rest)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Long warm-up (∼35 min at low intensity, including 5 min at moderate and 3 min at high intensity)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Short warm-up
Number of subjects: 14

Group type: COMPARATOR
Intervention: Long warm-up
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Test 2 (after warm-up)
Number of subjects: 14
Study: 34240490

Group type: EXPERIMENTAL
Intervention: Care programme based on Comfort Theory
Number of subjects: 120

Group type: COMPARATOR
Intervention: Routine nursing care
Number of subjects: 120
Study: 33091549

Group type: EXPERIMENTAL
Intervention: PRP+HA
Number of subjects: 122

Group type: COMPARATOR
Intervention: PRP
Number of subjects: 122

Group type: COMPARATOR
Intervention: PRP and PRP+HA
Number of subjects: 122
Study: 33016036

Group type: EXPERIMENTAL
Intervention: Protopine and Nuciferine syrup, 10 ml, once a day, for 8 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo (flavoured coloured water), 10 ml, once a day, for 8 weeks
Number of subjects: 100
Study: 35695009

Group type: EXPERIMENTAL
Intervention: Aerobic strength training (physical exercise group, PEG)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Breathing exercises (respiratory physiotherapy group, RPG)
Number of subjects: 23
Study: 33771947

Group type: EXPERIMENTAL
Intervention: Multiple-point linear method
Number of subjects: 86

Group type: COMPARATOR
Intervention: Multiple-point polynomial method
Number of subjects: 86

Group type: COMPARATOR
Intervention: 2-point method
Number of subjects: 86

Group type: COMPARATOR
Intervention: Velocity of the last repetition of a set to failure
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Individual V1RM
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: General V1RM
Number of subjects: 86
Study: 32842367

Group type: EXPERIMENTAL
Intervention: One shot of carboplatin (76 mg/kg, i.p.)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Two shots of carboplatin (76 mg/kg, i.p., one-week interval)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (group A)
Number of subjects: 18
Study: 34953219

Group type: EXPERIMENTAL
Intervention: Topiramate 100 mg/day
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 32320537

Group type: EXPERIMENTAL
Intervention: mobile high-frequency chest wall oscillation (mHFCWO)
Number of subjects: 0

Group type: COMPARATOR
Intervention: standard nonmobile high-frequency chest wall oscillation (sHFCWO)
Number of subjects: 0
Study: 34694240

Group type: EXPERIMENTAL
Intervention: Helmet noninvasive ventilation (NIV) with specific settings
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Awake prone positioning for 6-hour sessions
Number of subjects: 2

Group type: COMPARATOR
Intervention: High-flow nasal oxygen (HFNO)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Conventional management
Number of subjects: 2
Study: 32755104

Group type: EXPERIMENTAL
Intervention: Alcohol dose 0.06%
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Alcohol dose 0.08%
Number of subjects: 41

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study: 34322853

Group type: EXPERIMENTAL
Intervention: Prolonged-release fampridine (PR-FAM) 10-mg tablet twice daily
Number of subjects: 4646
Study: 33220215

Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard oral iron therapy
Number of subjects: 0
Study: 35750461

Group type: EXPERIMENTAL
Intervention: Exercise-training plus supplementation (Ex + Suppl, n=34)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Usual care (control, n=36)
Number of subjects: 70
Study: 33273328

Group type: EXPERIMENTAL
Intervention: NK + ART
Number of subjects: 20

Group type: COMPARATOR
Intervention: ART
Number of subjects: 20
Study: 32240469

Group type: EXPERIMENTAL
Intervention: I-View videolaryngoscope
Number of subjects: 0

Group type: COMPARATOR
Intervention: McGrath Mac videolaryngoscope
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study: 33684207

Group type: EXPERIMENTAL
Intervention: Text&Quit (T&Q)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Text4Coach (T4C)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 32465771

Group type: EXPERIMENTAL
Intervention: IVIG + conventional antimicrobial therapy
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional antimicrobial therapy alone
Number of subjects: 40
Study: 32113628

Group type: EXPERIMENTAL
Intervention: Adjuvanted RSV vaccine
Number of subjects: 1900

Group type: EXPERIMENTAL
Intervention: Self-collected nasal swabs
Number of subjects: 1900

Group type: COMPARATOR
Intervention: Site-collected swabs
Number of subjects: 1900

Group type: EXPERIMENTAL
Intervention: ARA‐RI endpoint definition
Number of subjects: 1900

Group type: EXPERIMENTAL
Intervention: Sensitivity analysis requiring ≥2 lower respiratory symptoms
Number of subjects: 1900
Study: 36130751

Group type: EXPERIMENTAL
Intervention: iSupport for dementia carers
Number of subjects: 350

Group type: COMPARATOR
Intervention: Standardised information about caring for someone with dementia (control-comparison)
Number of subjects: 350
Study: 32017092

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri-containing lozenges (test group, n=36)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo (control group, n=36)
Number of subjects: 72
Study: 33308033

Group type: EXPERIMENTAL
Intervention: Black older adults
Number of subjects: 259

Group type: EXPERIMENTAL
Intervention: Lower mobility performance/functioning scores
Number of subjects: 259
Study: 34460425

Group type: EXPERIMENTAL
Intervention: Specialized Nutritious Foods (SNFs)
Number of subjects: 522

Group type: EXPERIMENTAL
Intervention: Host fecal mRNA transcripts
Number of subjects: 522

Group type: COMPARATOR
Intervention: Lactulose:mannitol (L:M) test
Number of subjects: 522
Study: 33928883

Group type: EXPERIMENTAL
Intervention: Deutetrabenazine (fixed-dose 12-36 mg)
Number of subjects: 514

Group type: EXPERIMENTAL
Intervention: Deutetrabenazine (flexible-dose)
Number of subjects: 514

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 514
Study: 32081945

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sham group (control)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: OMT
Number of subjects: 32
Study: 36115192

Group type: EXPERIMENTAL
Intervention: Lu AF35700 10 mg
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Lu AF35700 20 mg
Number of subjects: 697

Group type: COMPARATOR
Intervention: Active comparator (risperidone or olanzapine)
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Lu AF35700 (both doses)
Number of subjects: 697

Group type: EXPERIMENTAL
Intervention: Lu AF35700
Number of subjects: 697
Study: 33387497

Group type: EXPERIMENTAL
Intervention: Endocrine therapy plus S-1
Number of subjects: 1930

Group type: COMPARATOR
Intervention: Endocrine therapy alone
Number of subjects: 1930
Study: 34622767

Group type: EXPERIMENTAL
Intervention: Tocilizumab
Number of subjects: 3617

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 3617

Group type: EXPERIMENTAL
Intervention: Abatacept
Number of subjects: 3617

Group type: EXPERIMENTAL
Intervention: Sarilumab
Number of subjects: 3617

Group type: EXPERIMENTAL
Intervention: Sirukumab
Number of subjects: 3617

Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 3617

Group type: EXPERIMENTAL
Intervention: Secukinumab 75 mg
Number of subjects: 3617

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3617

Group type: EXPERIMENTAL
Intervention: All biologic agents
Number of subjects: 3617
Study: 32820982

Group type: EXPERIMENTAL
Intervention: Cycling for 60 min between 60th and 120th minutes of dialysis (Session B)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Cycling for 60 min between 150th and 210th minutes of dialysis (Session C)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Without cycling (Session A)
Number of subjects: 7
Study: 33402518

Group type: EXPERIMENTAL
Intervention: Repetitive Peripheral Magnetic Stimulation (rPMS)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Repetitive Peripheral Magnetic Stimulation (rPMS) plus Physiokinesiotherapy (PKT)
Number of subjects: 41
Study: 32564996

Group type: EXPERIMENTAL
Intervention: Escape room activity
Number of subjects: 193
Study: 32236417

Group type: EXPERIMENTAL
Intervention: Motivation-phase interventions for 6 weeks
Number of subjects: 517
Study: 33185776

Group type: EXPERIMENTAL
Intervention: Enhancing Dyadic Communication (EDC)
Number of subjects: 1509
Study: 32014649

Group type: EXPERIMENTAL
Intervention: GSM900 exposure
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: TETRA exposure
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (sham exposure)
Number of subjects: 60
Study: 33641712

Group type: EXPERIMENTAL
Intervention: Case management intervention
Number of subjects: 24

Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 24